Hartford Investment Management Co. Has $3.80 Million Stock Position in Humana Inc. (NYSE:HUM)

Hartford Investment Management Co. lowered its position in Humana Inc. (NYSE:HUM) by 14.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 8,299 shares of the insurance provider’s stock after selling 1,431 shares during the period. Hartford Investment Management Co.’s holdings in Humana were worth $3,799,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of the stock. Dorsey & Whitney Trust CO LLC lifted its stake in shares of Humana by 2.6% in the 3rd quarter. Dorsey & Whitney Trust CO LLC now owns 817 shares of the insurance provider’s stock valued at $397,000 after acquiring an additional 21 shares during the last quarter. UMB Bank n.a. lifted its stake in shares of Humana by 2.8% in the 3rd quarter. UMB Bank n.a. now owns 805 shares of the insurance provider’s stock valued at $392,000 after acquiring an additional 22 shares during the last quarter. Vestcor Inc lifted its stake in shares of Humana by 0.3% in the 4th quarter. Vestcor Inc now owns 8,292 shares of the insurance provider’s stock valued at $4,247,000 after acquiring an additional 22 shares during the last quarter. First Financial Corp IN lifted its stake in shares of Humana by 7.2% in the 4th quarter. First Financial Corp IN now owns 343 shares of the insurance provider’s stock valued at $157,000 after acquiring an additional 23 shares during the last quarter. Finally, Exencial Wealth Advisors LLC lifted its stake in shares of Humana by 4.1% in the 4th quarter. Exencial Wealth Advisors LLC now owns 582 shares of the insurance provider’s stock valued at $298,000 after acquiring an additional 23 shares during the last quarter. Institutional investors own 92.38% of the company’s stock.

Insider Activity at Humana

In other Humana news, Director Jorge S. Mesquita bought 545 shares of the business’s stock in a transaction on Tuesday, February 20th. The shares were bought at an average cost of $367.09 per share, for a total transaction of $200,064.05. Following the transaction, the director now owns 2,578 shares in the company, valued at approximately $946,358.02. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 0.32% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on HUM. Truist Financial restated a “hold” rating and set a $550.00 price target on shares of Humana in a report on Friday, January 19th. TD Cowen reduced their price target on Humana from $427.00 to $396.00 and set a “buy” rating on the stock in a report on Tuesday. Oppenheimer restated an “outperform” rating and set a $630.00 price target on shares of Humana in a report on Wednesday, January 17th. Deutsche Bank Aktiengesellschaft downgraded Humana from a “buy” rating to a “hold” rating and reduced their target price for the stock from $595.00 to $360.00 in a report on Thursday, January 25th. Finally, Cantor Fitzgerald reiterated a “neutral” rating and set a $391.00 target price on shares of Humana in a report on Thursday. Eleven analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $468.74.

Humana Trading Up 1.3 %

Shares of Humana stock traded up $3.98 during trading hours on Thursday, hitting $312.04. The company’s stock had a trading volume of 794,308 shares, compared to its average volume of 2,096,501. The company has a market capitalization of $37.65 billion, a PE ratio of 15.63, a P/E/G ratio of 1.79 and a beta of 0.45. The business has a fifty day moving average of $354.91 and a 200 day moving average of $437.79. The company has a quick ratio of 1.59, a current ratio of 1.59 and a debt-to-equity ratio of 0.63. Humana Inc. has a 1-year low of $299.23 and a 1-year high of $541.21.

Humana (NYSE:HUM) last released its quarterly earnings data on Thursday, January 25th. The insurance provider reported ($0.11) earnings per share for the quarter, missing analysts’ consensus estimates of $0.76 by ($0.87). The firm had revenue of $26.46 billion during the quarter, compared to analyst estimates of $25.47 billion. Humana had a return on equity of 19.44% and a net margin of 2.34%. The firm’s revenue was up 17.9% on a year-over-year basis. During the same period last year, the business earned $1.62 EPS. As a group, equities analysts forecast that Humana Inc. will post 16.02 EPS for the current year.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 26th. Stockholders of record on Friday, March 29th will be paid a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.13%. The ex-dividend date is Wednesday, March 27th. Humana’s payout ratio is 17.86%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.